Archive des événements passés du site Louvain Drug Research Institute
You are viewing All events
-
Prof. Nick Van Gastel, DDUV - Targeting transient metabolic dependencies to overcome chemoresistance in leukemia15 NovNovember 15, 2021 - 1pm - Auditoire Maisin Prof. Nick Van Gastel, DDUV Targeting transient metabolic dependencies to overcome chemoresistance in leukemia Related publication: van Gastel N, Spinelli JB, Sharda A, Schajnovitz A, Baryawno N, Rhee C, Oki T, Grace E, Soled HJ, Milosevic J, Sykes DB, Hsu PP, Vander Heiden MG, Vidoudez C, Trauger SA, Haigis MC, Scadden DT.En savoir plusProf. Nick Van Gastel, DDUV - Targeting transient metabolic dependencies to overcome chemoresistance in leukemia15 NovNovember 15, 2021 - 1pm - Auditoire Maisin Prof. Nick Van Gastel, DDUV Targeting transient metabolic dependencies to overcome chemoresistance in leukemia Related publication: van Gastel N, Spinelli JB, Sharda A, Schajnovitz A, Baryawno N, Rhee C, Oki T, Grace E, Soled HJ, Milosevic J, Sykes DB, Hsu PP, Vander Heiden MG, Vidoudez C, Trauger SA, Haigis MC, Scadden DT.
-
Prof. Jean-Paul Dehoux - Procédures et fonctionnement de la commission d'éthique pour l'expérimentation animale du secteur (UCL/SSS) selon les législations récentes08 NovNovember 08, 2021 - 1pm - Auditoire Maisin Prof. Jean-Paul Dehoux, DVM, MSc, PhD et Professeur extraordinaire, MEDE et ASS Procédures et fonctionnement de la commission d'éthique pour l'expérimentation animale du secteur (UCL/SSS) selon les législations récentes. Info: francoise.vanbambeke@uclouvain.beEn savoir plusProf. Jean-Paul Dehoux - Procédures et fonctionnement de la commission d'éthique pour l'expérimentation animale du secteur (UCL/SSS) selon les législations récentes08 NovNovember 08, 2021 - 1pm - Auditoire Maisin Prof. Jean-Paul Dehoux, DVM, MSc, PhD et Professeur extraordinaire, MEDE et ASS Procédures et fonctionnement de la commission d'éthique pour l'expérimentation animale du secteur (UCL/SSS) selon les législations récentes. Info: francoise.vanbambeke@uclouvain.be
-
Elia BOZZATO- ADDB - Multi-drug loaded nanomedicine hydrogel for the treatment of glioblastoma28 OctThursday October 28, 2021, 4pm, Auditoire Maisin Elia BOZZATO Advanced Drug Delivery and Biomaterials (ADDB) Multi-drug loaded nanomedicine hydrogel for the treatment of glioblastoma Director: Prof. Véronique Préat – Co-director: Dr Chiara Bastiancich Related publications: Bastiancich*, C., Bozzato*, E., et al. (2019).En savoir plusElia BOZZATO- ADDB - Multi-drug loaded nanomedicine hydrogel for the treatment of glioblastoma28 OctThursday October 28, 2021, 4pm, Auditoire Maisin Elia BOZZATO Advanced Drug Delivery and Biomaterials (ADDB) Multi-drug loaded nanomedicine hydrogel for the treatment of glioblastoma Director: Prof. Véronique Préat – Co-director: Dr Chiara Bastiancich Related publications: Bastiancich*, C., Bozzato*, E., et al. (2019).
-
Prof. Andrea Bonetto, Department of surgery, School of Medecine, Indiana University - Musculoskeletal defects induced by cancer and its treatments18 OctOctober 18, 2021 - 1-2pm - Auditoire Maisin Prof. Andrea Bonetto, Department of surgery, School of Medecine, Indiana University Musculoskeletal defects induced by cancer and its treatments Related publications : Joshua R Huot, Fabrizio Pin, Andrea Bonetto. Muscle weakness caused by cancer and chemotherapy is associated with loss of motor unit connectivity. Am J Cancer Res.En savoir plusProf. Andrea Bonetto, Department of surgery, School of Medecine, Indiana University - Musculoskeletal defects induced by cancer and its treatments18 OctOctober 18, 2021 - 1-2pm - Auditoire Maisin Prof. Andrea Bonetto, Department of surgery, School of Medecine, Indiana University Musculoskeletal defects induced by cancer and its treatments Related publications : Joshua R Huot, Fabrizio Pin, Andrea Bonetto. Muscle weakness caused by cancer and chemotherapy is associated with loss of motor unit connectivity. Am J Cancer Res.
-
Julie Vanacker, PhD, chargée des études cliniques académiques UCLouvain - Etudes cliniques académiques: mode d'emploi et requis réglementaires11 OctOctober 11 – 1-2pm – Auditoire Maisin Julie Vanacker, PhD, chargée des études cliniques académiques UCLouvain Etudes cliniques académiques: mode d'emploi et requis réglementaires Info : francoise.vanbambeke@uclouvain.beEn savoir plusJulie Vanacker, PhD, chargée des études cliniques académiques UCLouvain - Etudes cliniques académiques: mode d'emploi et requis réglementaires11 OctOctober 11 – 1-2pm – Auditoire Maisin Julie Vanacker, PhD, chargée des études cliniques académiques UCLouvain Etudes cliniques académiques: mode d'emploi et requis réglementaires Info : francoise.vanbambeke@uclouvain.be
-
Prof. Charles PILETTE, IREC/PNEU - Mucosal immunity in chronic obstructive pulmonary disease: focus on the airway epithelium04 OctOctober 4 – 1-2pm – Auditoire 51B Prof. Charles PILETTE, IREC/PNEU Mucosal immunity in chronic obstructive pulmonary disease: focus on the airway epithelium Related publications: Gohy S, Detry B, Lecocq M, Bouzin C, Weynand B, Sibille Y, and Pilette C.En savoir plusProf. Charles PILETTE, IREC/PNEU - Mucosal immunity in chronic obstructive pulmonary disease: focus on the airway epithelium04 OctOctober 4 – 1-2pm – Auditoire 51B Prof. Charles PILETTE, IREC/PNEU Mucosal immunity in chronic obstructive pulmonary disease: focus on the airway epithelium Related publications: Gohy S, Detry B, Lecocq M, Bouzin C, Weynand B, Sibille Y, and Pilette C.
-
Prof. Laurent GATTO, CBIO/DDUV - Présentation des activités de la plateforme de bioinformatique20 SepMonday, September 20 – 1-2pm - Auditoire 51B Prof. Laurent GATTO, CBIO/DDUV Présentation des activités de la plateforme de bioinformatique Info: françoise.vanbambeke@uclouvain.beEn savoir plusProf. Laurent GATTO, CBIO/DDUV - Présentation des activités de la plateforme de bioinformatique20 SepMonday, September 20 – 1-2pm - Auditoire 51B Prof. Laurent GATTO, CBIO/DDUV Présentation des activités de la plateforme de bioinformatique Info: françoise.vanbambeke@uclouvain.be
-
Hervé POILVACHE - NMSK IREC and TFAR FACM - In-vitro and in-vivo study of biofilm disruption strategies for the treatment of Prosthetic Joint Infections20 SepMonday 20 September, 5.15 pm, Auditoire central Maisin Hervé POILVACHE NMSK - IREC and TFAR - FACM (Cellular and Molecular Pharmacology) In-vitro and in-vivo study of biofilm disruption strategies for the treatment of Prosthetic Joint Infections Directors: Olivier Cornu (NMSK - IREC) et Françoise Van Bambeke (TFAR - FACM) Related publications: Poilvache, H., et al. (2020).En savoir plusHervé POILVACHE - NMSK IREC and TFAR FACM - In-vitro and in-vivo study of biofilm disruption strategies for the treatment of Prosthetic Joint Infections20 SepMonday 20 September, 5.15 pm, Auditoire central Maisin Hervé POILVACHE NMSK - IREC and TFAR - FACM (Cellular and Molecular Pharmacology) In-vitro and in-vivo study of biofilm disruption strategies for the treatment of Prosthetic Joint Infections Directors: Olivier Cornu (NMSK - IREC) et Françoise Van Bambeke (TFAR - FACM) Related publications: Poilvache, H., et al. (2020).
-
Arina KOZLOVA - CMFA - Design, Synthesis and Evaluation of Original 1-H-indol-3-yl Heterocyclic Derivatives as Tryptophan 2,3-Dioxygenase Inhibitors01 SepSeptember 1st, 2021, 5pm, Auditoire central Maisin Arina KOZLOVA Medicinal Chemistry (CMFA) Design, Synthesis and Evaluation of Original 1-H-indol-3-yl Heterocyclic Derivatives as Tryptophan 2,3-Dioxygenase Inhibitors Director : Raphaël Frédérick, co-director : Benoît Van den Eynde. Related publications : Kozlova A, Frédérick R.En savoir plusArina KOZLOVA - CMFA - Design, Synthesis and Evaluation of Original 1-H-indol-3-yl Heterocyclic Derivatives as Tryptophan 2,3-Dioxygenase Inhibitors01 SepSeptember 1st, 2021, 5pm, Auditoire central Maisin Arina KOZLOVA Medicinal Chemistry (CMFA) Design, Synthesis and Evaluation of Original 1-H-indol-3-yl Heterocyclic Derivatives as Tryptophan 2,3-Dioxygenase Inhibitors Director : Raphaël Frédérick, co-director : Benoît Van den Eynde. Related publications : Kozlova A, Frédérick R.
-
PhD Week 202120 MayMay 20-21, 2021, 1-5pm Be with us virtually on Teams, and support the current LDRI PhD researchers. 20 oral presentations will be presented by the PhD candidates on Thursday 20 Rejoindre la conversation (microsoft.com) and Friday 21 Rejoindre la conversation (microsoft.com). You can find the detailed scientific program in the booklet posted on the LDRI Oasis spaEn savoir plusPhD Week 202120 MayMay 20-21, 2021, 1-5pm Be with us virtually on Teams, and support the current LDRI PhD researchers. 20 oral presentations will be presented by the PhD candidates on Thursday 20 Rejoindre la conversation (microsoft.com) and Friday 21 Rejoindre la conversation (microsoft.com). You can find the detailed scientific program in the booklet posted on the LDRI Oasis spa